
Erlonat Erlotinib 150 mg are an oral targeted therapy used for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer.
| Manufacturer | Natco |
| Generic Name | Erlotinib |
| Strength | 150 mg |
| Pack size | 30 Tablets |
| Used For | Lung and Pancreatic Cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
| Package | USD | GBP | AUD | PHP | TND | KRW | RON | HKD | MYR | THB | SGD | AED | SAR | QAR | KWD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 Tablets | $125 | £93 | A$174 | ₱7,836 | د.ت363.88 | ₩167,388 | lei 566 | HK$980 | RM509 | ฿4,128 | S$158 | د.إ459.13 | ر.س469.38 | ر.ق455.13 | د.ك38.125 |
Erlotinib is a targeted therapy that inhibits cancer cell growth, especially in cancers with specific genetic mutations.
This medication offers targeted therapy options that can improve outcomes and quality of life for patients with specific types of cancer.
Erlotinib is a targeted anticancer medicine that blocks the epidermal growth factor receptor (EGFR), a protein that helps cancer cells grow and multiply. By inhibiting this receptor, Erlotinib slows or stops the growth of cancer cells, helping to delay disease progression and, in some cases, reduce tumor size.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.